MiDura-Study (Neuro-Patch in Duraplasty)
- Conditions
 - DuraplastyTumor, BrainHydrocephalusDural FistulaVascular MalformationMeningiomaChiari MalformationTethered CordCraniotomySpinal Surgery
 
- Registration Number
 - NCT04189172
 
- Lead Sponsor
 - Aesculap AG
 
- Brief Summary
 The aim of this study is to collect systematically and proactively data regarding the performance of Neuro-Patch, like complications and handling, under daily clinical practice when used as intended by the manufacturer
- Detailed Description
 Not available
Recruitment & Eligibility
- Status
 - ACTIVE_NOT_RECRUITING
 
- Sex
 - All
 
- Target Recruitment
 - 328
 
- Written informed consent
 - Age > 18 years
 - Duraplasty using Neuro-Patch® according to the Instructions for Use
 
- Use in infected regions
 - Use in open cerebrocranial traumata
 - Use in open spina bifida
 - Known hypersensitivity to implant materials
 - Pregnancy
 - Representation by a legal guardian or under involuntary commitment
 
Study & Design
- Study Type
 - OBSERVATIONAL
 
- Study Design
 - Not specified
 
- Primary Outcome Measures
 Name Time Method Incidence of complications until follow-up (up to one year after surgery) Incidence of complications, with (potential) causal relationship to Neuro-Patch
- Secondary Outcome Measures
 Name Time Method Handling measures Intraoperative Evaluation of handling characteristics using a questionnaire containing 5-level Likert scales (excellent, very good, good, fair, poor)
Incidence of complications not related to Neuro Patch until follow-up (up to one year after surgery) Incidence of complications, without causal relationship to Neuro-Patch
Trial Locations
- Locations (4)
 Service de Neurochirurgie, Hôpital de la Cavale Blanche
🇫🇷Brest, France
Hopital Pierre Wertheimer - HCL
🇫🇷Bron, France
Klinik für Neurochirurgie, Universitätsklinikum des Saarlandes
🇩🇪Homburg/Saar, Germany
Krankenhaus Ludmillenstift
🇩🇪Meppen, Germany
Service de Neurochirurgie, Hôpital de la Cavale Blanche🇫🇷Brest, France
